Table 4. Outcomes.

	Ad, EGFR mt (-)	NSCLC, EGFR mt (+)	SQ
N	175	131	110
Survival
Dead	137	71	79
At our hospital	108	38	61
At other institutions	15	23	11
At home	14	10	7
Alive	20	37	10
Lost follow-up	18	23	21
Chemotherapy
Confirmed PD or death	154	103	88
Continued	2	17	0
Discontinued	173	86	110
PD	89	73	36
Completion of pre-defined courses	21	0	27
Adverse effects	29	13	18
Deteriorated conditions	25	12	24
Refusal	8	4	3
Transfer to other hospitals	1	5	0
Unknown cause	0	3	2